Accurate International
Provides a tumor organoid drug sensitivity detection platform for scientific research and clinical precision treatment
About Accurate International
Bio-Accurate is at the forefront of the organoid technology sector, focusing on advanced cancer research and personalized medicine. The company develops and utilizes organoids, which are miniaturized and simplified versions of organs, to create more accurate models for studying diseases and testing treatments. This innovative approach allows for more precise and effective drug development, ultimately leading to better patient outcomes. Bio-Accurate serves pharmaceutical companies, research institutions, and healthcare providers, operating within the biotechnology and healthcare markets. The business model is centered around providing cutting-edge organoid-based solutions and services, generating revenue through partnerships, licensing agreements, and direct sales of their proprietary technology. The recent completion of a Pre B round of financing, raising RMB 100 million, underscores the company's strong market position and growth potential. Key investors include Fortune Capital, Guangzhou Jinkong Fund, and GDD Industry Fund Investment Group, among others.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 21.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | May 2025 | $14M | $55M | Guangdong Technology Financial Group · Shenzhen Donghai Investment | ↗ |
| EARLY VC✓Equity / VC | Oct 2022 | $14M | $55M | Guangzhou Jinkong Fund · Fortune Capital · Funway Capital · Wanlian Securities | ↗ |
Growth signals
Latest recorded traffic for Accurate International is 290 monthly website visits, up 45% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Accurate International in the Guangzhou ecosystem
The Accurate International office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
- FCFortune Capital
- GFGuangzhou Jinkong Fund
- FCFunway Capital
Wanlian Securities- GFGDD Fund
- ZFZhonghe Anke Biomedical Industry Fund
Guangdong Technology Financial Group- SIShenzhen Donghai Investment
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Accurate International on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Accurate International’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









